1. Prognostic value of neutrophil-to-lymphocyte ratio for nasopharyngeal carcinoma
- Author
-
Jinyi Lang, Jun Yin, Yu-kun Luo, Mei Feng, and Yuan Qin
- Subjects
0301 basic medicine ,Oncology ,medicine.medical_specialty ,business.industry ,Hazard ratio ,Nasopharyngeal neoplasm ,General Medicine ,medicine.disease ,Confidence interval ,03 medical and health sciences ,030104 developmental biology ,0302 clinical medicine ,Nasopharyngeal carcinoma ,030220 oncology & carcinogenesis ,Internal medicine ,Meta-analysis ,medicine ,Carcinoma ,Biomarker (medicine) ,Neutrophil to lymphocyte ratio ,business - Abstract
BACKGROUND The prognostic value of the neutrophil-to-lymphocyte ratio (NLR) for nasopharyngeal carcinoma (NPC) remains controversial. This study was designed to provide a more accurate assessment of the prognostic value, based on a meta-analysis. METHODS A comprehensive search for relevant studies published before June 2016 was performed using the PubMed, Cochrane Library, and Web of Science databases. The correlations of NLR with overall survival (OS) and progression-free survival (PFS) were evaluated for NPC. Hazard ratios (HRs) and associated 95% confidence intervals (CIs) were calculated to estimate the effects. RESULTS Six studies with a total of 4359 NPC patients were included in this meta-analysis. The pooled results showed that, among patients with NPC, elevated pretreatment NLR was associated with poorer OS (HR = 1.74, 95% CI = 1.45-2.10) and PFS (HR = 1.48, 95% CI = 1.30-1.69). Subgroup analyses indicated that the use of different cut-off values for NLR ( .05). CONCLUSIONS This meta-analysis indicates that elevated pretreatment NLR might be a valuable predicative biomarker of poor prognosis for patients with NPC.
- Published
- 2017